X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (43463) 43463
Book Review (7008) 7008
Publication (3074) 3074
Newsletter (1208) 1208
Conference Proceeding (137) 137
Newspaper Article (107) 107
Book Chapter (104) 104
Magazine Article (73) 73
Dissertation (41) 41
Trade Publication Article (7) 7
Web Resource (5) 5
Paper (4) 4
Transcript (4) 4
Book / eBook (3) 3
Report (2) 2
Streaming Video (2) 2
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35795) 35795
humans (34036) 34036
male (17255) 17255
female (16684) 16684
interferon-alpha - therapeutic use (14675) 14675
middle aged (13379) 13379
adult (12715) 12715
interferon-alpha (11800) 11800
recombinant proteins (9493) 9493
antiviral agents - therapeutic use (8098) 8098
aged (7287) 7287
interferon (7161) 7161
treatment outcome (7065) 7065
animals (6767) 6767
hepatitis c, chronic - drug therapy (6427) 6427
interferon-alpha - administration & dosage (6253) 6253
oncology (6053) 6053
gastroenterology & hepatology (5544) 5544
interferon alpha (5344) 5344
drug therapy, combination (5304) 5304
immunology (4999) 4999
therapy (4896) 4896
interferon-alpha - adverse effects (4888) 4888
ribavirin - therapeutic use (4703) 4703
biological response modifiers (4574) 4574
hepatitis c (4534) 4534
interferon-alpha - pharmacology (4006) 4006
mice (3930) 3930
abridged index medicus (3789) 3789
polyethylene glycols - therapeutic use (3491) 3491
hepacivirus - genetics (3441) 3441
ribavirin (3432) 3432
health aspects (3193) 3193
hepatitis c virus (3145) 3145
care and treatment (3140) 3140
cancer (3105) 3105
virology (2995) 2995
infection (2977) 2977
genotype (2926) 2926
antiviral agents - administration & dosage (2741) 2741
hematology (2737) 2737
antineoplastic agents - therapeutic use (2727) 2727
adolescent (2685) 2685
antiviral agents - adverse effects (2638) 2638
hepatitis c - drug therapy (2610) 2610
expression (2538) 2538
virus-infection (2535) 2535
time factors (2489) 2489
pharmacology & pharmacy (2409) 2409
research (2408) 2408
infectious diseases (2326) 2326
biochemistry & molecular biology (2180) 2180
analysis (2168) 2168
prognosis (2130) 2130
recombinant proteins - therapeutic use (2129) 2129
drug therapy (2117) 2117
ribavirin - administration & dosage (2114) 2114
antineoplastic combined chemotherapy protocols - therapeutic use (2005) 2005
hepatitis c, chronic - virology (1995) 1995
follow-up studies (1982) 1982
retrospective studies (1933) 1933
hepatitis (1919) 1919
viral load (1910) 1910
cells, cultured (1864) 1864
medicine, general & internal (1835) 1835
immunotherapy (1779) 1779
cytokines (1758) 1758
risk factors (1753) 1753
cell biology (1730) 1730
hepacivirus - drug effects (1728) 1728
rna, viral - blood (1695) 1695
prospective studies (1643) 1643
cell line (1633) 1633
interferon-alpha - metabolism (1620) 1620
plus ribavirin (1618) 1618
carcinoma, renal cell - drug therapy (1611) 1611
dose-response relationship, drug (1608) 1608
kidney neoplasms - drug therapy (1573) 1573
dendritic cells (1549) 1549
drug administration schedule (1531) 1531
cells (1521) 1521
polyethylene glycols - administration & dosage (1519) 1519
young adult (1512) 1512
survival (1509) 1509
hepatitis c, chronic - complications (1506) 1506
interferon-alpha - immunology (1486) 1486
aged, 80 and over (1485) 1485
ribavirin - adverse effects (1480) 1480
combined modality therapy (1469) 1469
virus diseases (1445) 1445
medicine, research & experimental (1439) 1439
activation (1438) 1438
antiviral agents - pharmacology (1433) 1433
chronic hepatitis-c (1362) 1362
child (1361) 1361
signal transduction (1341) 1341
hepatitis b, chronic - drug therapy (1324) 1324
article (1321) 1321
chronic myelogenous leukemia (1320) 1320
genetic aspects (1318) 1318
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (40185) 40185
French (845) 845
Chinese (792) 792
German (764) 764
Japanese (654) 654
Russian (505) 505
Spanish (427) 427
Polish (206) 206
Italian (127) 127
Korean (84) 84
Hungarian (69) 69
Czech (66) 66
Portuguese (62) 62
Turkish (32) 32
Dutch (29) 29
Serbian (25) 25
Croatian (22) 22
Ukrainian (19) 19
Swedish (17) 17
Danish (15) 15
Slovak (12) 12
Hebrew (10) 10
Norwegian (8) 8
Finnish (7) 7
Romanian (7) 7
Bosnian (4) 4
Slovenian (4) 4
Bulgarian (2) 2
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Kohla, M and Gish, R
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 07/2015, Volume 13, Issue 7, p. e113
Journal Article
NATURE REVIEWS UROLOGY, ISSN 1759-4812, 05/2017, Volume 14, Issue 5
Intermittent sunitinib treatment is a feasible first-line approach in patients with renal cell carcinoma (RCC), providing a median progression-free survival... 
INTERFERON-ALPHA | UROLOGY & NEPHROLOGY
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 02/2015, Volume 104, Issue 2, p. 407
  Benzyl alcohol (BA) is the most widely used antimicrobial preservative in multidose protein formulations, and has been shown to cause protein aggregation.... 
Biological response modifiers | Interferon alpha
Journal Article
ANNALS OF THE RHEUMATIC DISEASES, ISSN 0003-4967, 03/2017, Volume 76, Issue 3
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 09/2011, Volume 208, Issue 10, pp. 2005 - 2016
Despite lack of tumor control in many models, spontaneous T cell priming occurs frequently in response to a growing tumor. However, the innate immune... 
MEDICINE, RESEARCH & EXPERIMENTAL | METASTATIC MELANOMA | INTERFERON-ALPHA | DYING CELLS | COLONY-STIMULATING FACTOR | TUMOR-ANTIGENS | REJECTION | PROSTATE-CANCER | INNATE IMMUNE-RESPONSE | RECEPTOR | IMMUNOLOGY | LYMPHOCYTES-T
Journal Article
Multiple Sclerosis and Related Disorders, ISSN 2211-0348, 04/2019, Volume 29, pp. 154 - 154
Journal Article
Journal Article
Brain, Behavior, and Immunity, ISSN 0889-1591, 2019
Interferon (IFN)-α treatment for hepatitis C virus (HCV) is a well-recognized clinical model for inflammation-induced depression, but the brain cellular... 
Interferon-alpha | Depression | Serum | Inflammation | Neurogenesis | Apoptosis | Hippocampal progenitor cells
Journal Article
BLOOD, ISSN 0006-4971, 08/2014, Volume 124, Issue 7, pp. 1119 - 1126
Histiocytoses are a group of heterogeneous diseases that mostly comprise Langerhans cell histiocytosis (LCH) and non-LCH. The association of LCH with non-LCH... 
CARDIAC INVOLVEMENT | INTERFERON-ALPHA | EOSINOPHILIC GRANULOMA | PULMONARY INVOLVEMENT | DENDRITIC CELLS | BRAF MUTATIONS | FOLLOW-UP | PATIENT | SKIN | OF-THE-LITERATURE | HEMATOLOGY
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 11/2015, Volume 495, Issue 1, p. 608
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2015, Volume 13, Issue 5.5, pp. 679 - 681
Antiangiogenic therapies remain the standard of care in the front-line setting for renal cell carcinoma, although vascular endothelial growth factor (VEGF)... 
INTERFERON-ALPHA | ONCOLOGY | SUNITINIB | SORAFENIB
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 07/2015, Volume 33, Issue 21, pp. 2384 - U88
Purpose On the basis of evidence that resistance to vascular endothelial growth factor (VEGF) receptor inhibition is caused by hypoxia-driven residual VEGF and... 
BIOMARKERS | SURVIVAL | INTERFERON-ALPHA | PAZOPANIB | EVEROLIMUS | EFFICACY | ONCOLOGY | DOUBLE-BLIND | SUNITINIB | TOXICITY | TUMORS
Journal Article
2013, Topical talks : talks of interest in the biomedical and life sciences
Web Resource
GUT, ISSN 0017-5749, 02/2013, Volume 62, Issue 2, pp. 290 - 298
Objective Treatment with peginterferon alpha-2a (PegIFN) for 48 weeks is the standard of care for selected HBeAg-negative patients chronically infected with... 
TRIAL | E-ANTIGEN | LAMIVUDINE | ENTECAVIR | INTERFERON-ALPHA | SUSTAINED RESPONSE | RETREATMENT | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 06/2019, Volume 42, Issue 5, p. 143
Strategies to stabilize remissions by specific elimination of residual acute myeloid leukemia (AML) blasts are needed. Leukemia-derived dendritic cell... 
Cell proliferation | Dendritic cells | Interferon alpha | Health aspects
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.